DK0711148T3 - Dobbeltfasede multilamellære lipidblærer - Google Patents

Dobbeltfasede multilamellære lipidblærer

Info

Publication number
DK0711148T3
DK0711148T3 DK94922214T DK94922214T DK0711148T3 DK 0711148 T3 DK0711148 T3 DK 0711148T3 DK 94922214 T DK94922214 T DK 94922214T DK 94922214 T DK94922214 T DK 94922214T DK 0711148 T3 DK0711148 T3 DK 0711148T3
Authority
DK
Denmark
Prior art keywords
lipid
blisters
double
phase
multilamellar lipid
Prior art date
Application number
DK94922214T
Other languages
English (en)
Inventor
Marianna Foldvari
Original Assignee
Pharmaderm Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaderm Lab Ltd filed Critical Pharmaderm Lab Ltd
Application granted granted Critical
Publication of DK0711148T3 publication Critical patent/DK0711148T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fats And Perfumes (AREA)
DK94922214T 1993-07-28 1994-07-28 Dobbeltfasede multilamellære lipidblærer DK0711148T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9810293A 1993-07-28 1993-07-28
PCT/CA1994/000409 WO1995003787A1 (en) 1993-07-28 1994-07-28 Biphasic multilamellar lipid vesicles

Publications (1)

Publication Number Publication Date
DK0711148T3 true DK0711148T3 (da) 2001-01-02

Family

ID=22267097

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94922214T DK0711148T3 (da) 1993-07-28 1994-07-28 Dobbeltfasede multilamellære lipidblærer

Country Status (10)

Country Link
EP (1) EP0711148B1 (da)
AT (1) ATE195866T1 (da)
AU (1) AU7343894A (da)
CA (1) CA2168260C (da)
DE (1) DE69425750T2 (da)
DK (1) DK0711148T3 (da)
ES (1) ES2152324T3 (da)
GR (1) GR3034777T3 (da)
PT (1) PT711148E (da)
WO (1) WO1995003787A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0722323B1 (en) * 1994-08-05 1999-09-22 Inpharma S.A. Compositions containing troxerutine complexed with phosphatidylcholine for topical treatment of erectile impotence
US5718917A (en) * 1995-12-15 1998-02-17 Harvard Scientific Corporation PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction
GB9605915D0 (en) * 1996-03-21 1996-05-22 Univ Bruxelles Liposome encapsulated amphiphilic drug compositions
US6416740B1 (en) * 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
US5993852A (en) * 1997-08-29 1999-11-30 Pharmaderm Laboratories Ltd. Biphasic lipid vesicle composition for transdermal administration of an immunogen
BE1011899A6 (fr) 1998-04-30 2000-02-01 Ucb Sa Compositions pharmaceutiques gelifiables utilisables.
KR20060123170A (ko) * 2003-10-24 2006-12-01 알자 코포레이션 지질 입자의 제조방법
WO2008000534A1 (de) * 2006-06-30 2008-01-03 Gertrud Langhoff Solubilisatformulierungen
EP2134353B1 (en) * 2007-03-30 2016-11-16 Helix Biopharma Corp. Biphasic lipid-vesicle composition and method for treating cervical dysplasia by intravaginal delivery
FR2939313B1 (fr) * 2008-12-10 2012-03-23 St Hubert Procede de preparation de vesicules a caractere hydrophobe comprenant une cavite interne hydrophobe.
US20120021036A1 (en) * 2009-01-15 2012-01-26 The Regents Of The University Of California Composite nanostructures and methods for making and using them
US9668474B2 (en) 2012-02-10 2017-06-06 Stepan Company Structured surfactant suspending systems
GB201202333D0 (en) * 2012-02-10 2012-03-28 Stepan Co Structured surfactant suspending systems
US10159646B2 (en) 2013-08-12 2018-12-25 Altum-Avro Pharma Partnership Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery
US8986732B2 (en) 2013-08-12 2015-03-24 Helix Biopharma Corporation Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery
CN107106421B (zh) * 2014-12-30 2020-10-27 赛特瑞恩股份有限公司 表皮生长因子和脂质体的混合型多层纳米结构及其制造方法
DK3512495T3 (da) 2016-09-15 2022-12-05 Camurus Ab Formuleringer af prostacyklinanaloger
EP3630067A4 (en) * 2017-05-26 2021-08-11 Altum Pharmaceuticals Inc. GIVING A BIPHASIC CANNABINOID
WO2019246286A1 (en) 2018-06-19 2019-12-26 Neon Therapeutics, Inc. Neoantigens and uses thereof
TWI848045B (zh) * 2019-01-30 2024-07-11 德商巴地斯顏料化工廠 供個人護理應用之液晶脂質顆粒之化妝品組合物
KR20220070246A (ko) 2019-09-23 2022-05-30 디디에스 리서치 인크. 침투 증진제를 갖는 지질 소포 조성물
MX2023011157A (es) 2021-03-24 2024-01-25 Glo Pharma Inc Peptidos y metodos para reducir la pigmentacion de la piel.
KR20240102989A (ko) * 2021-11-04 2024-07-03 글로 파마, 인크. 화장품 적용을 위한 방법 및 조성물
CN115531319B (zh) * 2022-11-25 2023-05-05 仙乐健康科技股份有限公司 一种高稳定性脂质体及其制备方法和用途
WO2025121442A2 (en) * 2023-12-05 2025-06-12 L'oreal Stable composition with excellent texture

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS607932A (ja) * 1983-06-29 1985-01-16 Dai Ichi Seiyaku Co Ltd リポソーム懸濁液およびその製法
US5160669A (en) * 1988-03-03 1992-11-03 Micro Vesicular Systems, Inc. Method of making oil filled paucilamellar lipid vesicles
WO1990012565A1 (en) * 1989-04-25 1990-11-01 Nattermann, A. & Cie. Gmbh Water-containing formulations with phospholipids
CA2038945A1 (en) * 1989-08-01 1991-02-02 Norman D. Weiner Topical delivery of peptides/proteins entrapped in dehydration/rehydration liposomes
WO1993000894A1 (en) * 1991-07-03 1993-01-21 Scott Nathan E Prostaglandin e2 treatment of impotence

Also Published As

Publication number Publication date
WO1995003787A1 (en) 1995-02-09
GR3034777T3 (en) 2001-02-28
ATE195866T1 (de) 2000-09-15
CA2168260A1 (en) 1995-02-09
DE69425750T2 (de) 2001-04-26
DE69425750D1 (de) 2000-10-05
PT711148E (pt) 2001-02-28
EP0711148B1 (en) 2000-08-30
EP0711148A1 (en) 1996-05-15
ES2152324T3 (es) 2001-02-01
AU7343894A (en) 1995-02-28
CA2168260C (en) 2000-04-11

Similar Documents

Publication Publication Date Title
ES2152324T3 (es) Vesiculas lipidicas multilaminares bifasicas.
WO2001039744A3 (en) Radiation sensitive liposomes
ATE52411T1 (de) Zubereitung von arzneimittelhaltigen lipidvesikeln und verfahren zu deren herstellung.
FI973320A7 (fi) Kiinteitä aktiiviainetta sisältäviä valmisteita
BR9508913A (pt) Preparação de lipossomas multivesiculares para liberação controlada de agentes ativos
DE69631970D1 (de) Archaeoliposome, koenzym q10 enthaltende archaeoliposome und koenzym q10 enthaltende liposome als adjuvans und wirkstoffabgabevehikel
FR2760193B1 (fr) Lipides et complexes de lipides cationiques et de substances actives, notamment pour la transfection de cellules
SI1051174T2 (sl) Gastroprotektirane omeprazolne mikrogranule, postopek za pridobivanje le-teh in farmacevtski pripravki
DK725888D0 (da) Overtrukne aktive stoffer
PL322688A1 (en) Cages for holding pasty and liquid preparations with active substance
FI972542L (fi) Transdermaalijärjestelmä useamman aktiivisen aineen samanaikaista antamista varten
EA199900715A1 (ru) Липидные комплексы и липосомы совершенно нерастворимых комплексов платины
FI961437A0 (fi) Vaikuttavan aineen luovuttava systeemi
DE69530368D1 (de) Vinca-alkaloid vesikel mit erhöhter wirksamkeit und tumor-zielausrichtung
ES2134846T3 (es) Formulacion de antibiotico y uso para infecciones resistentes a farmacos.
HUP9903363A3 (en) Preparation for the transport of an active substance across biological barriers
HU9601476D0 (en) Process for echancing the stability of liposomal suspensions containing hydrophilic active agents
DK0927222T3 (da) Termoplastiske polyurethaner indeholdende virksomme stoffer
ATE226843T1 (de) Mittel zur tumortherapie auf liposomenbasis, die tamoxifen enthalten
IL117943A (en) Dihalopropene compounds and insecticides containing them as active ingredients
TR199903211T2 (xx) Azasteroitler içeren çözeltiler.
PL327584A1 (en) Active substance quckly releasing tablet containing tolphenamica acid or its pharmaceutically acceptable salt
GB2303791B (en) Method of preparing a predetermined active agent stock solution for liposomal microencapsulation of active agents for agricultural uses
ATE228575T1 (de) Wirkstoffkombinationen
HRP960254B1 (en) Combinations of active fungicidal agents